<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Heparanase, endo-beta-D-glucuronidase, degrades <z:chebi fb="0" ids="24500">heparan</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi> <z:chebi fb="0" ids="18085">glycosaminoglycans</z:chebi> - the principal <z:chebi fb="5" ids="18154">polysaccharide</z:chebi> of the basement membrane and extracellular matrix </plain></SENT>
<SENT sid="1" pm="."><plain>Heparanase activity plays a decisive role in biological processes associated with remodeling of the extracellular matrix, such as <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In the hematopoietic system, heparanase is thought to be associated with <z:mpath ids='MPATH_458'>normal</z:mpath> differentiation and function of myeloid cells and platelets </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated heparanase polymorphisms in patients with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL), <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM) </plain></SENT>
<SENT sid="4" pm="."><plain>Significant correlation was found between rs11099592 and rs6535455 heparanase gene (HPSE) single nucleotide polymorphisms (SNPs) and ALL (chi2(1d.f.)=4.96, P=0.026) </plain></SENT>
<SENT sid="5" pm="."><plain>Genotype frequency comparisons revealed a significant association with rs4693602 (chi2(2d.f.)=7.276, P=0.026) in MM patients and rs4364254 (chi2(2d.f.)=6.226, P=0.044) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>Examination of HPSE gene <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression by real-time RT-PCR indicated a significant low HPSE gene expression level in ALL patients and a high expression level in MM and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients, compared to healthy controls </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, statistically significant correlation was found between heparanase <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression level and three HPSE gene SNPs (rs4693608, rs11099592 and rs4364254) among healthy individuals </plain></SENT>
<SENT sid="8" pm="."><plain>These data suggest that certain HPSE gene SNPs may contribute to basal heparanase gene expression and that alterations in this gene are an important determinant in the pathogenesis of ALL, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and MM </plain></SENT>
</text></document>